Avaneb vist homme?
resumes trading at 09:45 ET
GORXi conference call käib praegu, väga palju selgust pole saanud:
GORX GeoPharma on Conference Call (7.37 +0.56) -- Update --
Co says they are pleased to announce that they received FDA approval for Mucotrol; has been looking at marketing partners to team up with; give the patient number of 300,000 for potential market... co says addressing the issue because some people misconstrued the original press release as stating that a drug was given approval when in facct it was a medical device, co did not intend for it to be perceived that way... Co asked why they called it a prescription product and why did they back track on guidance: co states that product is technically dubbed a prescription product, for guidance they had not determined actual guidance, they were trying to show people what the market opportunity was not necessarily what they would be able to do... co says it is not really a device but technically it is a tablet, they are just unable to refer to it as a drug; was originally going to be a drug, but evolved into a device.
Ühe tegelase kommentaar selle peale:
GORX a new product 1/2 tablet 1/2 wafer.. Wablet a reg trademark
GORX GeoPharma on Conference Call (7.37 +0.56) -- Update --
Co says they are pleased to announce that they received FDA approval for Mucotrol; has been looking at marketing partners to team up with; give the patient number of 300,000 for potential market... co says addressing the issue because some people misconstrued the original press release as stating that a drug was given approval when in facct it was a medical device, co did not intend for it to be perceived that way... Co asked why they called it a prescription product and why did they back track on guidance: co states that product is technically dubbed a prescription product, for guidance they had not determined actual guidance, they were trying to show people what the market opportunity was not necessarily what they would be able to do... co says it is not really a device but technically it is a tablet, they are just unable to refer to it as a drug; was originally going to be a drug, but evolved into a device.
Ühe tegelase kommentaar selle peale:
GORX a new product 1/2 tablet 1/2 wafer.. Wablet a reg trademark
GORX turuväärtus ei ole midagi erilist ca 57milli näiteks konkureerivat toodet väljatöötaval CuraGen-il (CRGN) on see 360 milli. Sealjuures on GORX suutnud paar aastat isegi väikest kasumit näidata, samas kui konkurent põletab raha pöörase kiirusega.
Mis arvate, kas GORX on hype või mitte? Igaljuhul 7$ tase ei ole selle aktsia jaoks midagi erilist.
Mis arvate, kas GORX on hype või mitte? Igaljuhul 7$ tase ei ole selle aktsia jaoks midagi erilist.